Stony Brook Medicine Conducts COVID-19 Treatment Research
An accomplished physician and clinical researcher, Dr. Elliott Bennett-Guerrero has served as a professor and vice chairman at the Stony Brook School of Medicine for the past five years. Dr. Elliott Bennett-Guerrero is currently heading a study that hopes to develop new treatments for patients with COVID-19.
Stony Brook Medicine received official approval from the U.S. Food and Drug Administration to conduct a randomized controlled patient study of 500 individuals from the Long Island area. This study is based on existing evidence suggesting that the blood plasma of recovered COVID-19 patients may contain the key to an effective COVID-19 treatment.
The plasma of COVID-19 survivors is rich in antibodies that combat the novel coronavirus and the development of the disease that it brings. The use of similar antibodies has proven effective in the treatment of other disease outbreaks that range from the influenza pandemic of 1918 to the spread of Ebola in 2014.
